檢索結果 - Hyeonjeong Kang
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
-
5
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD 由 Jongbok Lee, Hyeonjeong Kang, Branson Chen, Yoosu Na, Ismat Khatri, Fraser Soares, Housheng Hansen He, Arjun Law, Tianzhong Pan, Armin Gerbitz, Xiaoyu Zhu, Mark D. Minden, Li Zhang
出版 2025Artigo -
6
Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms 由 Jong Bok Lee, Mark D. Minden, Weihsu C. Chen, Elena Streck, Branson Chen, Hyeonjeong Kang, Andrea Arruda, Dalam Ly, Sandy D. Der, Sohyeong Kang, Paulina Achita, Cheryl D’Souza, Yueyang Li, Richard W. Childs, John E. Dick, Li Zhang
出版 2017Artigo -
7
Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production 由 Jong Bok Lee, Dilshad H. Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Konopleva, Michael Andreeff, Mark D. Minden, Zhang Li, Aaron D. Schimmer
出版 2021Artigo
相關主題
Cancer research
Medicine
Biology
Immunology
Internal medicine
Leukemia
Cancer
Immune system
Myeloid leukemia
Biochemistry
Cell biology
Chemistry
Immunotherapy
Lung cancer
Oncology
Receptor
Stem cell
Adoptive cell transfer
Apoptosis
Bioinformatics
Blockade
Bone marrow
CD8
Cancer therapy
Cell therapy
Chemotherapy
Chronic lymphocytic leukemia
Computational biology
Cytotoxicity
Graft-versus-host disease